Similar tenders from other countries.
Showing 1 to 20
* Price Registration * Acquisition Of Medicines And/Or Health Products, Which Were Granted In The Presentations And Concentrations Registered With Anvisa Prescribed In The Medical Prescriptions Present In The Lawsuits. Agreement 87 Galantamine Hydrobromide, 8 Mg Hard Cap Lib Prol Quetiapine Hemifumarate, 200 Mg With Rev Lib Prol Insulin Aspart, 100 U/Ml Injectable X 3Ml Insulin Glargine, 300 U/Ml Sol Inj X 1.5 Ml Insulin Glulisine, 100 U/Ml Injectable X 3Ml Insulin Lispro, 100 Ui/Ml Sol Inj X 3 Ml Human Immunoglobulin, Subcutaneous Injectable 10%. Benserazide Hydrochloride + Levodopa, 100 Mg + 25 Mg With Miglustat, 100 Mg Cap Tafamidis Meglumine, 20 Mg Soft Cap Trastuzumab, 150 Mg Po Liof Sol Inj
14 Jan 2025
30 Jan 2025Subject: Electronic Auction - Acquisition Of General Injectable Medicines For The University Hospital Of The Federal University Of Roraima.
Securing Drug Items For The E-Market Platform
Human Normal Immunoglobulin 10%
Delivery Of Program And Other Medications
Zp/Czd/191/24 Supply Of Medicinal Products And Food For Special Medical Purposes Purchased As Part Of Targeted Import - 38 Packages
- Price Registration For The Acquisition Of Medicines Legal Demands *
60 Immunoglobulin E, Reagent For Test Determination C-12849
P-086/2025 C-12848 IMMUNOGLOBULIN A, REAGENT FOR DETERMINATION OF, TEST
P-087/2025 C-12849 Immunoglobulin E, Reagent For Determination Of, Test
P-088/2025 C-12851 Immunoglobulin G, Reagent For Determination Of, Test
P-089/2025 C-12855 Immunoglobulin M, Reagent For Determination Of, Test
Acquisition Of Human Immunoglobulin Sol Inj 5 G For Stock Replacement - Dr. Alberto Rassi State Hospital
- Price Registration For The Acquisition Of Medicines Legal Demands *
Supply (Contr 2024 0000869240)
The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Inputs: Human Immunoglobulin Concentration: 200Mg/Ml, Pharmaceutical Form: Injectable Solution - 10 Ml; Selumetinib Concentration: 10Mg; Selumetinib Concentration: 25Mg; Enzalutamide Concentration: 40Mg; Ruxolitinib Concentration: 5Mg; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 100 Ml; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 20 Ml; Medicinal Extract Active Ingredient: Cannabidiol Oil, Concentration: 50Mg/Ml, Pharmaceutical Form: Oral Solution Canabidiol Pratidonaduzzi 50 Mg/Ml, 30 Ml; Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Canabidiol Prati-Donaduzzi 200 Mg/Ml, 30 Ml And Lacosamide Concentration: 100Mg.
0000081/2024 Contr 2024 0000869240 +6.C436Hus Supply Of Successive Tract Of Reagents And Expendable Material, Availability Of Use And Maintenance Of Main And Auxiliary Equipment, For The Performance Of Analytical Determinations In The Laboratories/Units Of The Health Centers Of The Andalusian Health Service Of The Province Of Cádiz
Agreement 23 Injectable And Oral Medications For 36 Months
Delivery Of Medicinal Products And Medical Devices To The Military Institute Of Medicine – National Research Institute
- Price Registration For The Acquisition Of Medicines Legal Demands *
Tenders by Country